Ranbaxy falls 7% as Mylan sues FDA over launch of generic Lipitor - Livemint
×
Home Companies Industry Politics Money Opinion Budget 2018 LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×